Ex-Celgene, Sanofi, Stryker Execs Accused Of Insider Trading

Law360, New York (November 19, 2012, 7:02 PM EST) -- Onetime Celgene Corp., Sanofi-Aventis and Stryker Corp. executives were among six people hit with criminal charges Monday for allegedly participating in a New Jersey-based insider trading network that used confidential information on acquisitions or other corporate developments to generate more than $1.4 million in illegal profits.

From 2007 to this year, John Lazorchak, a former director of financial reporting at Celgene, repeatedly shared tips with friend Mark Cupo, who was a director of accounting and reporting at Sanofi, authorities said. Cupo allegedly funneled that information to...
To view the full article, register now.